Results 81 to 90 of about 30,059 (192)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy

Prostate Cancer, 2016
Purpose. In this study, we evaluated our experience with salvage brachytherapy after discovery of biochemical recurrence after a prior brachytherapy procedure. Methods and Materials.
John M. Lacy, William A. Wilson, Raevti Bole, Li Chen, Ali S. Meigooni, Randall G. Rowland, William H. St. Clair   +6 more
doaj   +1 more source

Immune Predictors of Radiotherapy Outcomes in Cervical Cancer

Advanced Science, Volume 13, Issue 16, 18 March 2026.
This study reveals dynamic immune remodeling in cervical cancer following radiotherapy. Single‐cell analysis identifies the C3/C3AR1 axis as a central mediator of epithelial–myeloid crosstalk, whose inhibition reduces treatment efficacy in mice. Guided by these insights, the eight‐feature machine‐learning model: Cervical Cancer Radiotherapy Immune ...
Linghao Wang, Jie Zhu, Zequn Ding, Zhiyuan Xie, Xingchen Liu, Feihong Zhang, Xiaojun Liu, Yan Zhang, Haiyan Chen   +8 more
wiley   +1 more source

Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy

BJUI Compass, Volume 7, Issue 3, March 2026.
Abstract Objectives To compare oncological outcomes after extended pelvic lymph node dissection (PLND) versus limited in patients with high‐risk prostate cancer (PCa) undergoing curative external beam radiation therapy (EBRT). Patients and Methods From 3627 men with PCa at a single centre between 2000 and 2013, 167 with high‐risk, age ≤75, Gleason ...
Georgios Daouacher, Jessica Carlsson, Pernilla Sundqvist, Mauritz Waldén   +3 more
wiley   +1 more source

A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review

Cancer Medicine, Volume 15, Issue 3, March 2026.
Etoposide mediated topoisomerase II inhibition in Cervical Cancer. ABSTRACT Background Etoposide is a semisynthetic derivative of podophyllotoxin and an FDA‐approved topoisomerase II inhibitor that induces DNA strand breaks leading to cancer cell death.
Nikitha Kotian, Yashaswini Reddy, Padmini Pai, Babitha Kampa Sundara   +3 more
wiley   +1 more source

Factors Associated With Risk Stratification and Overall Survival of Black South African Men With Non‐Metastatic Prostate Cancer

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Emerging evidence indicates significantly poorer overall survival for men with metastatic prostate cancer in resource‐limited settings than in high‐income countries. However, there is less understanding of the overall survival of non‐metastatic disease, which could inform early treatment strategies.
Raylton P. Chikwati, Monica Ewomazino Akokuwebe, Olaide O. Ojoniyi, Rebaone Petlele, Shane A. Norris, Audrey Pentz, Maureen Joffe, Sean Doherty, Timothy R. Rebbeck, Wenlong C. Chen   +9 more
wiley   +1 more source

CT Angiography-Guided Needle Insertion for Interstitial Brachytherapy in Locally Advanced Cervical Cancer

Diagnostics
CT angiography might be a suitable procedure to avoid arterial puncture in combined intracavitary and interstitial brachytherapy for cervical cancer curatively treated with combined chemoradiation and brachytherapy boost.
Alexandra Timea Kirsch-Mangu, Diana Cristina Pop, Alexandru Tipcu, Alexandra Ioana Andries, Gina Iulia Pasca, Zsolt Fekete, Andrei Roman, Alexandru Irimie, Claudia Ordeanu   +8 more
doaj   +1 more source

Systematic Review of Genomic‐Based Risk Stratification in Localised Prostate Cancer Treatment Optimisation: Clinical Impact and Health Economic Evidence

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Several genomic risk stratification tests are available to predict the risk of metastasis and mortality for prostate cancer patients at the time of diagnosis. However, the evidence supporting the clinical utility of genomic risk stratification tools is fragmented, posing challenges in assessing their real‐world clinical impact and ...
Juntao Lyu, Fan He, Niall M. Corcoran, Gang Chen, Hadi Akbarzadeh Khorshidi   +4 more
wiley   +1 more source

Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study

International Journal of Nanomedicine, 2018
Elham Shahhoseini,1 Prabhakar Ramachandran,1,2 William Roy Patterson,3 Moshi Geso1 1Discipline of Medical Radiation, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia; 2Department of Physical Sciences, Peter Mac Callum ...
Shahhoseini E, Ramachandran P, Patterson WR, Geso M   +3 more
doaj  

Nomogram Prediction Model and Prognostic Comparison of Cervical Clear Cell Carcinoma and Cervical Endometrioid Adenocarcinoma: A SEER Database Study

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Cervical clear cell adenocarcinoma (CCAC) and cervical endometrioid adenocarcinoma (CEAC) are rare and aggressive non‐HPV‐associated malignancies. Despite their histological similarities, these subtypes demonstrate distinct biological behaviors, presenting challenges in treatment and prognosis.
Jimiao Huang, Xiaoyan Li, Yiling Zhuang, Zhonghai Zhang, Junjie You, Hongwei Zhang, Jiamin Chen, Nianquan You, Rui Tang, Wuyuan Pan, Ruqi Fang, Suyu Li, Xiangqin Zheng   +12 more
wiley   +1 more source

Influence of Diagnostic and Treatment Delays on Survival Outcomes in Patients With Locally Advanced Rectal Cancer: A Multi‐Center Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Objective To investigate the impact of diagnostic and treatment delays on the prognosis of patients with locally advanced rectal cancer (LARC). Methods Retrospective analyses were performed in Chinese and American cohorts. The intervals from symptom onset to diagnosis and from diagnosis to initial treatment were defined as diagnostic and ...
Yutian Zhao, Jiahao Zhu, Benjie Xu, Peipei Shen, Fei Xu, Bo Yang, Shengjun Ji, Leyuan Zhou   +7 more
wiley   +1 more source